Published 6 issues per year
ISSN Print: 1045-4403
ISSN Online: 2162-6502
Indexed in
Association Studies of ERCC2 rs13181 Polymorphism with Pancreatic Cancer Susceptibility
ABSTRACT
Although the ERCC2 gene rs13181 polymorphism is involved in the pancreatic cancer pathogenic mechanism, there is no consistent finding. This meta-analysis aimed to determine the association between ERCC2 rs13181 polymorphism and pancreatic cancer. Related articles were searched against the PubMed database in a retrospective way. Additionally, the combined odds ratios (ORs) and the corresponding 95% confidence intervals (CIs) were calculated using the random- or fixed-effects model. Altogether, seven articles regarding ERCC2 gene rs13181 polymorphism were enrolled. The combined ORs regarding the relationship of ERCC2 rs13181 polymorphism with pancreatic cancer incidence showed significant differences in each genetic model (C vs. A: OR = 1.14, 95% CI = 1.04-1.26; CC vs. AA: OR = 1.53, 95% CI = 1.24-1.90; AC vs. AA: OR = 1.06, 95% CI 0.92-1.22; recessive model: OR = 1.50, 95% CI = 1.22-1.84; dominant model: OR = 1.16, 95% CI = 1.02-1.32). Additionally, we performed subgroup analysis stratified by race, which revealed that ERCC2 rs13181 polymorphism increased the risk of pancreatic cancer in Asian populations. This work suggests that the ERCC2 gene rs13181 polymorphism is related to pancreatic cancer risk in Asians.
-
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7-30.
-
Zheng Z, Zheng R, He Y, Sun X, Wang N, Chen T, Chen W. Risk factors for pancreatic cancer in china: A multi-center case-control study. J Epidemiol. 2016;26:64-70.
-
Klein AP. Genetic susceptibility to pancreatic cancer. Mol Carcinog. 2012;51:14-24.
-
Jalal S, Earley JN, Turchi JJ. DNA repair: From genome maintenance to biomarker and therapeutic target. Clin Cancer Res. 2011;17:6973-84.
-
Friedberg EC. How nucleotide excision repair protects against cancer. Nat Rev Cancer. 2001;1:22-33.
-
Ginsberg G, Angle K, Guyton K, Sonawane B. Polymorphism in the DNA repair enzyme XRCC1: Utility of current database and implications for human health risk assessment. Mutat Res Fundam Mol Mech Mutagen. 2011;727:1-15.
-
Cheng L, Sturgis EM, Eicher SA, Spitz MR, Wei Q. Expression of nucleotide excision repair genes and the risk for squamous cell carcinoma of the head and neck. Cancer. 2002;94:393-7.
-
Koeppel F, Poindessous V, Lazar V, Raymond E, Sarasin A, Larsen AK. Irofulven cytotoxicity depends on transcription-coupled nucleotide excision repair and is correlated with xpg expression in solid tumor cells. Clin Cancer Res. 2004;10:5604-13.
-
Jiang DK, Ren WH, Yao L, Wang WZ, Peng B, Yu L. Meta-analysis of association between TP53 Arg72Pro polymorphism and bladder cancer risk. Urology. 2012;76:765.e1-7.
-
He MG, Zheng K, Tan D, Wang ZX. Association between ERCC1 and ERCC2 gene polymorphisms and susceptibility to pancreatic cancer. Genet Mol Res. 2016;15(1). doi: 10.4238/gmr.15017879.
-
Hocevar BA, Kamendulis LM, Pu X, Perkins SM, Wang ZY, Johnston EL, DeWitt JM, Li L, Loehrer PJ, Klaunig JE, Chiorean EG. Contribution of environment and genetics to pancreatic cancer susceptibility. PLoS One. 2014;9:e90052.
-
Jiao L, Hassan MM, Bondy ML, Abbruzzese JL, Evans DB, Li DH. The XPD Asp312Asn and Lys751Gln poly-morphisms, corresponding haplotype, and pancreatic cancer risk. Cancer Lett. 2007;245:61-8.
-
McWilliams RR, Bamlet WR, Cunningham JM, Goode EL, de Andrade M, Boardman LA, Petersen GM. Poly-morphisms in DNA repair genes, smoking, and pancreatic adenocarcinoma risk. Cancer Res. 2008;68:4928-35.
-
Sileng A, Pan RH, Li GH, Wang W, Li JY, Zhang M, Li M, Zhang ZL, Lin J, Liao CX. ERCC1 rs3212986 and ERCC2 rs13181 gene polymorphisms contributes to the susceptibility to pancreatic cancer in a Chinese population. Int J Clin Exp Pathol. 2016;9:5687-93.
-
Ying MF, Zhao R. Role of single nucleotide polymorphisms of DNA repair genes in susceptibility to pancreatic cancer in Chinese population. Genet Mol Res. 2016;15(1). doi: 10.4238/gmr.15017273.
-
Zhao FL, Shang YH, Zeng C, Gao DD, Li K. Association of single nucleotide polymorphisms of DNA repair genes in NER pathway and susceptibility to pancreatic cancer. Int J Clin Exp Pathol. 2015;8:11579-86.
-
Yan Y, Liang H, Light M, Li T, Deng Y, Li M, Li S, Qin X. XPD Asp312Asn and Lys751Gln polymorphisms and breast cancer susceptibility: A meta-analysis. Tumour Biol. 2014;35:1907-15.
-
Li J, Pan L, Qin X, Chu H, Mu H, Wan G. Association between ERCC2 rs13181 polymorphism and ovarian cancer risk: An updated meta-analysis with 4024 subjects. Arch Gynecol Obstet. 2017;296:551-8.
-
de Boer J, Hoeijmakers JH. Nucleotide excision repair and human syndromes. Carcinogenesis. 2000;21:453-60.
-
Xue H, Lu Y, Lin B, Chen J, Tang F, Huang G. The effect of XPD/ERCC2 polymorphisms on gastric cancer risk among different ethnicities: A systematic review and meta-analysis. PLoS One. 2012;7:e43431.
-
Moisan F, Laroche-Clary A, Auzanneau C, Ricard N, Pourquier P, Robert J, Le Morvan V. Deciphering the role of the ERCC2 gene polymorphism on anticancer drug sensitivity. Carcinogenesis. 2012;33:962-8.
-
Duell EJ, Bracci PM, Moore JH, Burk RD, Kelsey KT, Holly EA. Detecting pathway-based gene-gene and gene-environment interactions in pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2008;17:1470-9.
-
Du Y, Su T, Zhao L, Tan X, Chang W, Zhang H, Cao G. Associations of polymorphisms in DNA repair genes and MDR1 gene with chemotherapy response and survival of non-small cell lung cancer. PLoS One. 2014;9:e99843.